Your browser doesn't support javascript.
loading
CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy.
Li, Xiaofei; Lu, Mingjie; Yuan, Manman; Ye, Jing; Zhang, Wei; Xu, Lingyan; Wu, Xiaohan; Hui, Bingqing; Yang, Yuchen; Wei, Bin; Guo, Ciliang; Wei, Min; Dong, Jie; Wu, Xingxin; Gu, Yanhong.
Affiliation
  • Li X; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Lu M; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yuan M; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
  • Ye J; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
  • Zhang W; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Xu L; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wu X; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Hui B; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yang Y; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wei B; Department of Oncology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
  • Guo C; Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China.
  • Wei M; Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China.
  • Dong J; Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu, China.
  • Wu X; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
  • Gu Y; Department of Oncology and Cancer Rehabilitation Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Oncoimmunology ; 11(1): 2118210, 2022.
Article in En | MEDLINE | ID: mdl-36092638
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma, Alveolar / Adenoviridae Infections / Oncolytic Viruses / Neoplasms Limits: Animals / Humans Language: En Journal: Oncoimmunology Year: 2022 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma, Alveolar / Adenoviridae Infections / Oncolytic Viruses / Neoplasms Limits: Animals / Humans Language: En Journal: Oncoimmunology Year: 2022 Document type: Article Affiliation country: China Country of publication: United States